HR-positive/HER2-negative breast cancer grows with estrogen or progesterone, lacking high HER2 protein levels, making hormone ...
Stephanie Wachtel found empowerment and control through areola tattooing, enhancing her sense of normalcy after breast cancer ...
Longer-term trial results show Voranigo may help control grade 2 IDH-mutated glioma after surgery for those who can delay ...
As Liver Cancer Awareness Month ends, Drs. Vogel and Yarchoan highlight the urgent need for greater awareness, support and ...
Stage 2 cervical cancer is classified into 2A and 2B, based on tumor spread and size, affecting treatment decisions. Diagnosis involves biopsies and imaging tests, including CT, MRI, and PET scans, to ...
Throughout my healing process, I also found humor. I always had a comedic personality, but I discovered that making people ...
In October 2025, the U.S. Food and Drug Administration (FDA) granted approval to multiple new cancer therapies and supportive ...
As Liver Cancer Awareness Month ends, Drs. Vogel and Yarchoan highlight the urgent need for greater awareness, support and resources for liver cancer.
As Liver Cancer Awareness Month ends, Drs. Vogel and Yarchoan highlight the urgent need for greater awareness, support and resources for liver cancer.
CURE spoke with Dr. Rosario Ligestri and Dr. Anna Berkenblit about the rising rate of pancreatic cancer in relatively younger adults. Following the Oct. 14, 2025 death of R&B singer D’Angelo from ...
The U.S. Food and Drug Administration (FDA) has approved two new biosimilars as reference products for Prolia (denosumab) and XGEVA® (denosumab): Stoboclo (denosumab-bmwo) and Osenvelt (denosumab-bmwo ...
Pancreatic cancer incidence is rising among younger adults, particularly those aged 15 to 39, due to lifestyle and genetic factors. Key risk factors include obesity, smoking, alcohol consumption, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results